Skip to main content

Advertisement

Log in

Monitoring EBV DNA in saliva for early diagnosis of EBV reactivation in solid tumour patients after allogeneic haematopoietic SCT

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Masucci MG, Ernberg I . Epstein–Barr virus: adaptation to a life within the immune system. Trends Microbiol 1994; 2: 125–130.

    Article  CAS  PubMed  Google Scholar 

  2. Young LS, Rickinson AB . Epstein–Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757–768.

    Article  CAS  PubMed  Google Scholar 

  3. Hentschke P, Barkholt L, Uzunel M, Mattsson J, Wersäll P, Pisa P et al. Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant 2003; 31: 253–261.

    Article  CAS  Google Scholar 

  4. Le Blanc K, Remberger M, Uzunel M, Mattsson J, Barkholt L, Ringdén O . A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation 2004; 78: 1014–1020.

    Article  CAS  PubMed  Google Scholar 

  5. Zetterquist H, Mattsson J, Uzunel M, Näsman-Björk I, Svenberg P, Tammik L et al. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant 2000; 25: 843–851.

    Article  CAS  PubMed  Google Scholar 

  6. Enbom M, Strand A, Falk KI, Linde A . Detection of Epstein–Barr virus, but not human herpes virus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction. Sex Transm Dis 2001; 28: 300–306.

    Article  CAS  PubMed  Google Scholar 

  7. Sundin M, Le Blanc K, Ringden O, Barkholt L, Omazic B, Lergin C et al. The role of HLA mismatch, splenectomy and recipient Epstein–Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91: 1059–1067.

    PubMed  Google Scholar 

  8. Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N et al. Tonsillar homing of Epstein–Barr virus-specific CD8+ T cells and the virus-host balance. J Clin Invest 2005; 115: 2546–2555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hentschke P, Omazic B, Mattsson J, Näsman-Björk I, Lundkvist I, Gigliotti D et al. T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Scand J Immunol 2005; 61: 285–294.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to the staff at the Centre for Allogeneic Stem Cell Transplantation, and we thank the Departments of Haematology and Paediatrics for their compassionate and competent patient care.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Barkholt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mollbrink, A., Falk, K., Linde, A. et al. Monitoring EBV DNA in saliva for early diagnosis of EBV reactivation in solid tumour patients after allogeneic haematopoietic SCT. Bone Marrow Transplant 44, 259–261 (2009). https://doi.org/10.1038/bmt.2009.5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.5

  • Springer Nature Limited

Navigation